Literature DB >> 18579699

Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species.

Nicholas J Kotloski1, Dean T Nardelli, Sara Heil Peterson, Jose R Torrealba, Thomas F Warner, Steven M Callister, Ronald F Schell.   

Abstract

We recently hypothesized that T helper 17 (Th17) cells and their associated cytokines are involved in the development of arthritis following infection with Borrelia burgdorferi. Here, we show that interleukin-23 (IL-23), a survival factor for Th17 cells, is required for the induction of arthritis in mice vaccinated with B. burgdorferi strain 297 and challenged with "Borrelia bissettii." When Borrelia-vaccinated and -challenged mice were given antibodies to the p19 subunit of IL-23, they failed to develop the histopathological changes observed in untreated vaccinated and challenged mice. In addition, viable B. bissettii organisms stimulated the secretion of IL-17 from Borrelia-immune lymph node cells during in vitro culture. When anti-IL-23 p19 antibody was included in cultures of B. bissettii organisms and Borrelia-immune lymph node cells, the production of IL-17 was reduced to levels observed in cultures containing immune cells alone. Taken together, these results support the hypothesis that Th17 cell-associated cytokines are involved in the development of Borrelia-mediated arthritis. These findings provide insight into previously overlooked immune mechanisms responsible for the development of Lyme arthritis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579699      PMCID: PMC2519303          DOI: 10.1128/CVI.00129-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  47 in total

1.  Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: a possible role as a "fine-tuning cytokine" in inflammation processes.

Authors:  Y Katz; O Nadiv; Y Beer
Journal:  Arthritis Rheum       Date:  2001-09

2.  Occurrence of severe destructive lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi.

Authors:  C L Croke; E L Munson; S D Lovrich; J A Christopherson; M C Remington; D M England; S M Callister; R F Schell
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 3.  The link between IL-23 and Th17 cell-mediated immune pathologies.

Authors:  Mandy J McGeachy; Daniel J Cua
Journal:  Semin Immunol       Date:  2007-12-03       Impact factor: 11.130

4.  Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.

Authors:  Sudeepta Aggarwal; Nico Ghilardi; Ming-Hong Xie; Frederic J de Sauvage; Austin L Gurney
Journal:  J Biol Chem       Date:  2002-11-03       Impact factor: 5.157

5.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.

Authors:  B Oppmann; R Lesley; B Blom; J C Timans; Y Xu; B Hunte; F Vega; N Yu; J Wang; K Singh; F Zonin; E Vaisberg; T Churakova; M Liu; D Gorman; J Wagner; S Zurawski; Y Liu; J S Abrams; K W Moore; D Rennick; R de Waal-Malefyt; C Hannum; J F Bazan; R A Kastelein
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

6.  Microbial lipopeptides induce the production of IL-17 in Th cells.

Authors:  C Infante-Duarte; H F Horton; M C Byrne; T Kamradt
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

7.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.

Authors:  Daniel J Cua; Jonathan Sherlock; Yi Chen; Craig A Murphy; Barbara Joyce; Brian Seymour; Linda Lucian; Wayne To; Sylvia Kwan; Tatyana Churakova; Sandra Zurawski; Maria Wiekowski; Sergio A Lira; Daniel Gorman; Robert A Kastelein; Jonathon D Sedgwick
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

8.  Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi.

Authors:  Matthew A Burchill; Dean T Nardelli; Douglas M England; David J DeCoster; John A Christopherson; Steven M Callister; Ronald F Schell
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

9.  Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: modulation by tumor necrosis factor alpha.

Authors:  John A Christopherson; Erik L Munson; Douglas M England; Cindy L Croke; Monica C Remington; Melanie L Molitor; David J DeCoster; Steven M Callister; Ronald F Schell
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

10.  Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells.

Authors:  Christoph Becker; Stefan Wirtz; Manfred Blessing; Jaana Pirhonen; Dennis Strand; Oliver Bechthold; Julia Frick; Peter R Galle; Ingo Autenrieth; Markus F Neurath
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

View more
  13 in total

1.  Infection of Interleukin 17 Receptor A-Deficient C3H Mice with Borrelia burgdorferi Does Not Affect Their Development of Lyme Arthritis and Carditis.

Authors:  Carrie E Lasky; Kara E Jamison; Darcie R Sidelinger; Carmela L Pratt; Guoquan Zhang; Charles R Brown
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

2.  Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice.

Authors:  Joseph Kuo; Dean T Nardelli; Thomas F Warner; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

3.  Role of interleukin-23 (IL-23) receptor signaling for IL-17 responses in human Lyme disease.

Authors:  Marije Oosting; Hadewych ter Hofstede; Frank L van de Veerdonk; Patrick Sturm; Bart-Jan Kullberg; Jos W M van der Meer; Mihai G Netea; Leo A B Joosten
Journal:  Infect Immun       Date:  2011-09-06       Impact factor: 3.441

4.  Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans.

Authors:  Klemen Strle; Daša Stupica; Elise E Drouin; Allen C Steere; Franc Strle
Journal:  Clin Infect Dis       Date:  2013-11-11       Impact factor: 9.079

5.  Interleukin-10 (IL-10) inhibits Borrelia burgdorferi-induced IL-17 production and attenuates IL-17-mediated Lyme arthritis.

Authors:  Emily S Hansen; Velinka Medić; Joseph Kuo; Thomas F Warner; Ronald F Schell; Dean T Nardelli
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

Review 6.  Th17 cytokines and arthritis.

Authors:  Erik Lubberts
Journal:  Semin Immunopathol       Date:  2010-02-04       Impact factor: 9.623

Review 7.  The role of T helper type 17 cells in inflammatory arthritis.

Authors:  S Sarkar; L A Cooney; D A Fox
Journal:  Clin Exp Immunol       Date:  2009-08-25       Impact factor: 4.330

Review 8.  Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens.

Authors:  Meredith M Curtis; Sing Sing Way
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

9.  T-Helper 17 Cell Cytokine Responses in Lyme Disease Correlate With Borrelia burgdorferi Antibodies During Early Infection and With Autoantibodies Late in the Illness in Patients With Antibiotic-Refractory Lyme Arthritis.

Authors:  Klemen Strle; Katherine B Sulka; Annalisa Pianta; Jameson T Crowley; Sheila L Arvikar; Anthony Anselmo; Ruslan Sadreyev; Allen C Steere
Journal:  Clin Infect Dis       Date:  2017-04-01       Impact factor: 9.079

10.  Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study.

Authors:  Anna J Henningsson; Ivar Tjernberg; Bo-Eric Malmvall; Pia Forsberg; Jan Ernerudh
Journal:  J Neuroinflammation       Date:  2011-04-20       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.